Ingredient news
O Positiv Adds PS to New MENO Brain Retail Launch
By Nutranexa News |
O Positiv says its new MENO Brain product uses phosphatidylserine in a menopause-focused brain-fog concept, adding another mass-retail demand signal for cognitive-positioned ingredients.
What Entered Retail
O Positiv said on January 13, 2026 that it was expanding at Target with three new women's health innovations, including MENO Brain.
The release positioned MENO Brain around brain fog, memory, and cognition, and listed phosphatidylserine among the ingredients in the formula.
What It Signals
This is notable because it places PS inside a menopause and midlife-wellness retail concept rather than a traditional healthy-aging or student-focus story.
That kind of repositioning can change the way buyers think about price targets, co-ingredient compatibility, and the documentation needed for broader consumer-audience scrutiny.
Buyer Takeaway
Ingredient teams tracking women's health should watch where PS appears in stress, hormone, or cognition-adjacent concepts and whether that shifts preferred source, format, or technical substantiation.
Retail expansion is a demand signal, not a claim shortcut, so compliant market translation still matters.